FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967289321> ?p ?o ?g. }

• W2967289321 abstract "Chronic pancreatitis (CP) is a progressive, fibro-inflammatory disease characterized by enzymatic autoactivation and subsequent fibrotic replacement of acinar cells. A significant proportion of patients develop pain, which may be due to many causes, including perineural inflammation, altered central processing of pain signals, parenchymal structural changes, and ductal obstruction. Currently there are no approved medical treatment options for CP-associated pain. NI-03 (camostat mesilate) is an orally administered serine protease inhibitor that reduces pancreatic enzyme activity and has been widely used for the treatment of CP-associated pain in Japan. The current study will assess the safety and efficacy of NI-03 for reduction of CP-associated pain in the USA. The current study consists of two phases. First, a phase I study will be performed to establish the pharmacokinetics and safety profile over a 1-week period following a single dose (100, 200, or 300 mg). Subsequently, a phase II study will be performed consisting of a double-blind, randomized, controlled trial (RCT). This RCT will evaluate the efficacy of each of the three doses of NI-03 given three times daily compared to placebo over 28 days. A 7-day, single-blind, run-in period will precede the double-blind phase to assess baseline pain characteristics. The primary efficacy outcome is the average of worst daily pain scores (numeric rating scale of 0–10) over the terminal 7 days of the study period compared to baseline. Secondary efficacy outcomes include change in opioid dose and quality of life measures, and time to first rescue intravenous analgesic. Adverse events will be recorded. NI-03 has been used successfully and safely in Japan to treat CP-associated pain. The aim of the current study is to assess the safety and efficacy of NI-03 using a rigorous RCT in a population in the USA. This study may fill an important clinical gap to provide an effective medical treatment option for CP-associated pain. ClinicalTrials.gov, NCT02693093 . Registered through the National Institutes of Health on 26 February 2016." @default.
• W2967289321 created "2019-08-22" @default.
• W2967289321 creator A5012767113 @default.
• W2967289321 creator A5039996110 @default.
• W2967289321 creator A5070856467 @default.
• W2967289321 date "2019-08-14" @default.
• W2967289321 modified "2023-09-24" @default.
• W2967289321 title "A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)" @default.
• W2967289321 cites W1512454558 @default.
• W2967289321 cites W1615119401 @default.
• W2967289321 cites W1986112329 @default.
• W2967289321 cites W2014864078 @default.
• W2967289321 cites W2053302654 @default.
• W2967289321 cites W2060900867 @default.
• W2967289321 cites W2104509804 @default.
• W2967289321 cites W2143651115 @default.
• W2967289321 cites W2187842317 @default.
• W2967289321 cites W2282364445 @default.
• W2967289321 cites W2320909684 @default.
• W2967289321 cites W2430627513 @default.
• W2967289321 cites W2592183014 @default.
• W2967289321 cites W2595114989 @default.
• W2967289321 cites W4238795694 @default.
• W2967289321 doi "https://doi.org/10.1186/s13063-019-3606-y" @default.
• W2967289321 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6694471" @default.
• W2967289321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31412955" @default.
• W2967289321 hasPublicationYear "2019" @default.
• W2967289321 type Work @default.
• W2967289321 sameAs 2967289321 @default.
• W2967289321 citedByCount "44" @default.
• W2967289321 countsByYear W29672893212020 @default.
• W2967289321 countsByYear W29672893212021 @default.
• W2967289321 countsByYear W29672893212022 @default.
• W2967289321 countsByYear W29672893212023 @default.
• W2967289321 crossrefType "journal-article" @default.
• W2967289321 hasAuthorship W2967289321A5012767113 @default.
• W2967289321 hasAuthorship W2967289321A5039996110 @default.
• W2967289321 hasAuthorship W2967289321A5070856467 @default.
• W2967289321 hasBestOaLocation W29672893211 @default.
• W2967289321 hasConcept C112705442 @default.
• W2967289321 hasConcept C126322002 @default.
• W2967289321 hasConcept C142724271 @default.
• W2967289321 hasConcept C168563851 @default.
• W2967289321 hasConcept C197934379 @default.
• W2967289321 hasConcept C204787440 @default.
• W2967289321 hasConcept C27081682 @default.
• W2967289321 hasConcept C2775967933 @default.
• W2967289321 hasConcept C2777014857 @default.
• W2967289321 hasConcept C535046627 @default.
• W2967289321 hasConcept C71924100 @default.
• W2967289321 hasConceptScore W2967289321C112705442 @default.
• W2967289321 hasConceptScore W2967289321C126322002 @default.
• W2967289321 hasConceptScore W2967289321C142724271 @default.
• W2967289321 hasConceptScore W2967289321C168563851 @default.
• W2967289321 hasConceptScore W2967289321C197934379 @default.
• W2967289321 hasConceptScore W2967289321C204787440 @default.
• W2967289321 hasConceptScore W2967289321C27081682 @default.
• W2967289321 hasConceptScore W2967289321C2775967933 @default.
• W2967289321 hasConceptScore W2967289321C2777014857 @default.
• W2967289321 hasConceptScore W2967289321C535046627 @default.
• W2967289321 hasConceptScore W2967289321C71924100 @default.
• W2967289321 hasIssue "1" @default.
• W2967289321 hasLocation W29672893211 @default.
• W2967289321 hasLocation W29672893212 @default.
• W2967289321 hasLocation W29672893213 @default.
• W2967289321 hasLocation W29672893214 @default.
• W2967289321 hasOpenAccess W2967289321 @default.
• W2967289321 hasPrimaryLocation W29672893211 @default.
• W2967289321 hasRelatedWork W1964352248 @default.
• W2967289321 hasRelatedWork W2003254263 @default.
• W2967289321 hasRelatedWork W2085830368 @default.
• W2967289321 hasRelatedWork W2135682290 @default.
• W2967289321 hasRelatedWork W2328878243 @default.
• W2967289321 hasRelatedWork W2553592838 @default.
• W2967289321 hasRelatedWork W2762492465 @default.
• W2967289321 hasRelatedWork W3207313530 @default.
• W2967289321 hasRelatedWork W4283171304 @default.
• W2967289321 hasRelatedWork W4317928308 @default.
• W2967289321 hasVolume "20" @default.
• W2967289321 isParatext "false" @default.
• W2967289321 isRetracted "false" @default.
• W2967289321 magId "2967289321" @default.
• W2967289321 workType "article" @default.